BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10910272)

  • 21. Protective effects of FTY720 on chronic allograft nephropathy by reducing late lymphocytic infiltration.
    Wang M; Liu S; Ouyang N; Song E; Lutz J; Heemann U
    Kidney Int; 2004 Sep; 66(3):1248-56. PubMed ID: 15327424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppression with FTY720 and cyclosporine A inhibits rejection of adult porcine islet xenografts in rats.
    Maeda A; Goto M; Zhang J; Bennet W; Groth CG; Korsgren O; Wennberg L
    Transplantation; 2003 Apr; 75(8):1409-14. PubMed ID: 12717240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of FTY720 on chronic cyclosporine nephropathy in rats.
    Kim JY; Lim SW; Li C; Kim JS; Ahn KO; Yang HJ; Choi BS; Kim YS; Kim J; Bang BK; Yang CW
    Transplantation; 2005 Nov; 80(9):1323-30. PubMed ID: 16314802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FTY720 prolongs clear corneal allograft survival with a differential effect on different lymphocyte populations.
    Mayer K; Birnbaum F; Reinhard T; Reis A; Braunstein S; Claas F; Sundmacher R
    Br J Ophthalmol; 2004 Jul; 88(7):915-9. PubMed ID: 15205237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of everolimus and cyclosporine A on intimal alpha-actin-positive cell dynamics of carotid allografts in mice.
    Matsumoto Y; Hof A; Baumlin Y; Müller M; Hof RP
    Transplantation; 2004 Aug; 78(3):345-51. PubMed ID: 15316361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FTY720 in combination with CsA inhibits islet xenograft rejection: a study in the pig-to-rat model.
    Zhang J; Song Z; Wijkström M; Bari S; Sundberg B; Nava S; Groth CG; Korsgren O; Wennberg L
    Transplant Proc; 2000 Aug; 32(5):1017. PubMed ID: 10936327
    [No Abstract]   [Full Text] [Related]  

  • 27. Differential effect of cyclosporine A and SDZ RAD on neointima formation of carotid allografts in apolipoprotein E-deficient mice.
    Matsumoto Y; Hof A; Baumlin Y; Hof RP
    Transplantation; 2003 Oct; 76(8):1166-70. PubMed ID: 14578747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of lymphocyte apoptosis in rat liver allograft with ongoing rejection by FTY720.
    Li XK; Tamura A; Fujino M; Guo L; Kakefuda T; Funeshima N; Enosawa S; Amari M; Naoe S; Amemiya H; Suzuki S
    Clin Exp Immunol; 2001 Feb; 123(2):331-9. PubMed ID: 11207666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of a novel immunosuppressant, FTY720, on allograft survival after renal transplant in rats.
    Ueda H; Takahara S; Azuma H; Kusaka M; Suzuki S; Katsuoka Y
    Eur Surg Res; 2000; 32(5):279-83. PubMed ID: 11111172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized controlled trial of FTY720 versus MMF in de novo renal transplantation.
    Tedesco-Silva H; Pescovitz MD; Cibrik D; Rees MA; Mulgaonkar S; Kahan BD; Gugliuzza KK; Rajagopalan PR; Esmeraldo Rde M; Lord H; Salvadori M; Slade JM;
    Transplantation; 2006 Dec; 82(12):1689-97. PubMed ID: 17198261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of SDZ RAD compared with CsA monotherapyand combined Rad/FTY720 treatment in a murine cardiac allotransplantation model.
    Nikolova Z; Hof A; Baumlin Y; Hof RP
    Transpl Immunol; 2001 Oct; 9(1):43-9. PubMed ID: 11680571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tacrolimus in combination with FTY720--an analysis of renal and blood parameters.
    Gallo AP; Silva LB; Franco M; Burdmann EA; Bueno V
    Int Immunopharmacol; 2006 Dec; 6(13-14):1919-24. PubMed ID: 17219691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
    Silva FR; Silva LB; Cury PM; Burdmann EA; Bueno V
    Int Immunopharmacol; 2006 Dec; 6(13-14):1911-8. PubMed ID: 17161344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.
    Yanagawa Y; Sugahara K; Kataoka H; Kawaguchi T; Masubuchi Y; Chiba K
    J Immunol; 1998 Jun; 160(11):5493-9. PubMed ID: 9605152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic effects of FTY720, a new immunosuppressive agent, in a murine model of acute viral myocarditis.
    Miyamoto T; Matsumori A; Hwang MW; Nishio R; Ito H; Sasayama S
    J Am Coll Cardiol; 2001 May; 37(6):1713-8. PubMed ID: 11345389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing.
    Chiba K; Yanagawa Y; Masubuchi Y; Kataoka H; Kawaguchi T; Ohtsuki M; Hoshino Y
    J Immunol; 1998 May; 160(10):5037-44. PubMed ID: 9590253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study.
    Kahan BD; Karlix JL; Ferguson RM; Leichtman AB; Mulgaonkar S; Gonwa TA; Skerjanec A; Schmouder RL; Chodoff L
    Transplantation; 2003 Oct; 76(7):1079-84. PubMed ID: 14557756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation.
    Hwang MW; Matsumori A; Furukawa Y; Ono K; Okada M; Iwasaki A; Hara M; Sasayama S
    Circulation; 1999 Sep; 100(12):1322-9. PubMed ID: 10491378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation.
    Suzuki S; Enosawa S; Kakefuda T; Shinomiya T; Amari M; Naoe S; Hoshino Y; Chiba K
    Transplantation; 1996 Jan; 61(2):200-5. PubMed ID: 8600623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.